Clinical trial
Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old)…
NCT00130364 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00130364 |
|---|---|
| Title | Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis |
| Official title | Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus, Placebo |
| Enrollment | 200 |
| Start date | Aug 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Aug 15, 2005 |
| Last update posted | Jan 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: